Key Metrics
CiteScore 

4.5
H-Index 

59
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

0.82
Recommended pre-submission checks
Powered by 

Topics Covered on Chemotherapy
Chemotherapy Journal Specifications
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1960 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Chemotherapy
Expression of Concern
- 21 Jan 2026
- Chemotherapy
Drug-drug interaction between toosendanin and tamoxifen and its potential mechanism.
- 23 Dec 2025
- Chemotherapy
Acknowledgement to Reviewers
- 10 Nov 2025
- Chemotherapy
Novel Insights into Epiploic Appendagitis in a Breast Cancer Patient on Abemaciclib: A Case Report
- 17 Sep 2025
- Chemotherapy
Therapeutic Drug Monitoring: A Driver to Precision Medicine for Patients with Hematological Malignancies
- 11 Aug 2025
- Chemotherapy
Role of a Therapeutic Drug Monitoring-Guided Strategy of Isavuconazole for Optimizing Efficacy/Safety Outcomes in Onco-Hematological Pediatric Patients: A Systematic Review
- 5 Aug 2025
- Chemotherapy
Expression of Concern
- 21 Jan 2026
- Chemotherapy
Drug-drug interaction between toosendanin and tamoxifen and its potential mechanism.
- 23 Dec 2025
- Chemotherapy
Acknowledgement to Reviewers
- 10 Nov 2025
- Chemotherapy
Novel Insights into Epiploic Appendagitis in a Breast Cancer Patient on Abemaciclib: A Case Report
- 17 Sep 2025
- Chemotherapy
Therapeutic Drug Monitoring: A Driver to Precision Medicine for Patients with Hematological Malignancies
- 11 Aug 2025
- Chemotherapy
Role of a Therapeutic Drug Monitoring-Guided Strategy of Isavuconazole for Optimizing Efficacy/Safety Outcomes in Onco-Hematological Pediatric Patients: A Systematic Review
- 5 Aug 2025
- Chemotherapy